Eleni Douni

发表

MUGEN mouse database; Animal models of human immunological diseases

Michael Zouberakis, Christina Chandras, George Kollias, 2007, Nucleic Acids Res..

Cheminformatics-aided discovery of small-molecule Protein-Protein Interaction (PPI) dual inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)

George Kollias, Georgia Melagraki, Thomas M. Mavromoustakos, 2017, PLoS Comput. Biol..

Meeting report from the 5th International Conference on Osteoimmunology 2014

Eleni Douni, 2014 .

A Splicing Mutation in the Novel Mitochondrial Protein DNAJC11 Causes Motor Neuron Pathology Associated with Cristae Disorganization, and Lymphoid Abnormalities in Mice

George Kollias, Elias Eliopoulos, Eleni Douni, 2014, PloS one.

Solvent Selection for Insoluble Ligands, a Challenge for Biological Assay Development: A TNF-α/SPD304 Study.

Eleni Douni, Vagelis Rinotas, G. Kontopidis, 2013, ACS medicinal chemistry letters.

A RANKL G278R mutation causing osteopetrosis identifies a functional amino acid essential for trimer assembly in RANKL and TNF.

George Kollias, Georg Schett, Elias Eliopoulos, 2012, Human molecular genetics.

On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease

George Kollias, Eleni Douni, G. Kollias, 1999, Immunological reviews.

The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease

George Kollias, Eleni Douni, G. Kollias, 1999, Annals of the rheumatic diseases.

In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis

George Kollias, Eleni Douni, Klaus Pfizenmaier, 1997, European journal of immunology.

A statistical approach for optimization of RANKL overexpression in Escherichia coli: purification and characterization of the protein.

Eleni Douni, Vagelis Rinotas, George Kontopidis, 2013, Protein expression and purification.

Rationally Designed Less Toxic SPD‐304 Analogs and Preliminary Evaluation of Their TNF Inhibitory Effects

George Kollias, Elias Eliopoulos, Eleni Douni, 2014, Archiv der Pharmazie.

The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor

George Kollias, Peter Scheurich, Eleni Douni, 1995, Cell.

A Critical Role of the p75 Tumor Necrosis Factor Receptor (p75TNF-R) in Organ Inflammation Independent of TNF, Lymphotoxin α, or the p55TNF-R

George Kollias, Eleni Douni, G. Kollias, 1998, The Journal of experimental medicine.

The role of TNF/TNFR in organ-specific and systemic autoimmunity: implications for the design of optimized 'anti-TNF' therapies.

George Kollias, Eleni Douni, G. Kollias, 2002, Current directions in autoimmunity.